BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28825477)

  • 1. Improved Method for the Identification and Validation of Allosteric Sites.
    Song K; Liu X; Huang W; Lu S; Shen Q; Zhang L; Zhang J
    J Chem Inf Model; 2017 Sep; 57(9):2358-2363. PubMed ID: 28825477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms.
    Lu S; Shen Q; Zhang J
    Acc Chem Res; 2019 Feb; 52(2):492-500. PubMed ID: 30688063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent computational advances in the identification of allosteric sites in proteins.
    Lu S; Huang W; Zhang J
    Drug Discov Today; 2014 Oct; 19(10):1595-600. PubMed ID: 25107670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.
    Huang W; Nussinov R; Zhang J
    Methods Mol Biol; 2017; 1529():439-446. PubMed ID: 27914066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based approaches to improve selectivity: CDK2-GSK3beta binding site analysis.
    Vulpetti A; Crivori P; Cameron A; Bertrand J; Brasca MG; D'Alessio R; Pevarello P
    J Chem Inf Model; 2005; 45(5):1282-90. PubMed ID: 16180905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyphony: superposition independent methods for ensemble-based drug discovery.
    Pitt WR; Montalvão RW; Blundell TL
    BMC Bioinformatics; 2014 Sep; 15(1):324. PubMed ID: 25265915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing an Allosteric Pocket of CDK2 with Small Molecules.
    Christodoulou MS; Caporuscio F; Restelli V; Carlino L; Cannazza G; Costanzi E; Citti C; Lo Presti L; Pisani P; Battistutta R; Broggini M; Passarella D; Rastelli G
    ChemMedChem; 2017 Jan; 12(1):33-41. PubMed ID: 27860401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a potential allosteric ligand binding site in CDK2.
    Betzi S; Alam R; Martin M; Lubbers DJ; Han H; Jakkaraj SR; Georg GI; Schönbrunn E
    ACS Chem Biol; 2011 May; 6(5):492-501. PubMed ID: 21291269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2.
    Li Y; Zhang J; Gao W; Zhang L; Pan Y; Zhang S; Wang Y
    Int J Mol Sci; 2015 Apr; 16(5):9314-40. PubMed ID: 25918937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of hidden allosteric sites as novel targets for allosteric drug design.
    Lu S; Ji M; Ni D; Zhang J
    Drug Discov Today; 2018 Feb; 23(2):359-365. PubMed ID: 29030241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting protein flexibility to predict the location of allosteric sites.
    Panjkovich A; Daura X
    BMC Bioinformatics; 2012 Oct; 13():273. PubMed ID: 23095452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPC Analysis of Multiple Binding Sites Communication and Allosteric Modulations in Drug Design: The HSP Case Study.
    Chiappori F; Milanesi L; Merelli I
    Curr Drug Targets; 2016; 17(14):1610-1625. PubMed ID: 26648062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering allosteric pathways in caspase-1 using Markov transient analysis and multiscale community detection.
    Amor B; Yaliraki SN; Woscholski R; Barahona M
    Mol Biosyst; 2014 Aug; 10(8):2247-58. PubMed ID: 24947802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing allostery: a novel approach to drug discovery.
    Lu S; Li S; Zhang J
    Med Res Rev; 2014 Nov; 34(6):1242-85. PubMed ID: 24827416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances on structure-informed drug discovery of cyclin-dependent kinase-2 inhibitors.
    Duca JS
    Future Med Chem; 2009 Nov; 1(8):1453-66. PubMed ID: 21426059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel nonpeptide allosteric inhibitors interrupting the interaction of CDK2/cyclin A3 by virtual screening and bioassays.
    Hu Y; Li S; Liu F; Geng L; Shu X; Zhang J
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4069-73. PubMed ID: 26316466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses.
    Huang M; Song K; Liu X; Lu S; Shen Q; Wang R; Gao J; Hong Y; Li Q; Ni D; Xu J; Chen G; Zhang J
    Nucleic Acids Res; 2018 Jul; 46(W1):W451-W458. PubMed ID: 29757429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ensemble performance index: an improved measure for assessing ensemble pose prediction performance.
    Korb O; McCabe P; Cole J
    J Chem Inf Model; 2011 Nov; 51(11):2915-9. PubMed ID: 21962010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric sites: remote control in regulation of protein activity.
    Guarnera E; Berezovsky IN
    Curr Opin Struct Biol; 2016 Apr; 37():1-8. PubMed ID: 26562539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Random Forest Model for Predicting Allosteric and Functional Sites on Proteins.
    Chen AS; Westwood NJ; Brear P; Rogers GW; Mavridis L; Mitchell JB
    Mol Inform; 2016 Apr; 35(3-4):125-35. PubMed ID: 27491922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.